ARCHIVES

Modality Combo Decreases Prostate Cancer Recurrence

This article is from The Cancer Letter archive.

Vol. 27 No. 8 | August 27, 2004

Download PDF Visit The Full Archive

Related Articles

DCT Faces Hard Choices, Clinical Group Need Re-Examination, Chabner tells BSC

November 12, 1982

FDA Authority To Remove Paclitaxel Patent Questioned.

February 9, 2001

Program Announcements n Animal Retroviruses, Other Topics, Approved

March 30, 1990

AZT, DDC Combination Increase CD4 Counts, NIAID Trial Finds

January 17, 1992

Tip O’Neill Testifies As Cancer Survivor At Hearing Called To Renew Commitment To ‘War On Cancer’

April 26, 1991

Pryce Introduces Bill To Reimbuse For Orally Administered Cancer Drugs.

May 4, 2001